{
  "docId": "019dd923-622c-750b-8b9a-1a3bea94baf9",
  "docSlug": "c358888161f0",
  "documentTitle": "Ginkgo Bioworks (DNA)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-10-06 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 172,
  "pageCount": 175,
  "prevPage": 171,
  "nextPage": 173,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses direct quotes to frame Ginkgo's strategic moves as reactive to Zymergen's failure.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-1a3bea94baf9/172",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9#slide-172",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Ginkgo was worried and tried to downplay its similarity to Zymergen after its stock collapsed",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-2b63-72e1-b602-3c40448acc0b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "A former executive indicated they both had the same “Foundry” technology, even using the same suppliers to equip their labs; that Ginkgo CEO’s “biggest fear was always Zymergen”; and that Ginkgo was worried after Zymergen’s stock imploded in August, and “announced all these deals to try to be able to show that they’re different.” An ex-employee who was a longtime direct report to the CEO stated “they’re very similar” with the only difference being that Zymergen wanted to specialize in a few verticals while Ginkgo wanted to be a generalist strain engineering CRO.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99a7cfda-4dcc-48e9-ae85-71b98dbfa9b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.74
      },
      "kind": "quote",
      "text": "“Ginkgo was quickly in defensive mode [after Zymergen’s stock collapsed] because they didn't want people to make that comparison, and so they announced all these deals to try to be able to show that they’re different. Maybe Ginkgo will be successful at some point, but when the rubber meets the road, you look at what products are out there. Who has been successful using your technology that has led to a meaningful product? And the answer is there isn't any.” - Former Ginkgo executive",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19913109-51dd-4573-9836-a5b5c87795a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "quote",
      "text": "“I think that in certain ways, they’re very similar. They competed on a number of very large-dollar number projects...I would say where Ginkgo and Zymergen diverged was a few years ago, Zymergen started to specialize in a few application areas: materials, ag, pharma, a few other one-offs. Whereas Ginkgo said, we’re not going to specialize. We want to be able to engineer everything. And so, the types of projects that the company took on varied from cannabis projects to materials to biodefense.” - Former Ginkgo employee, longtime direct report to CEO Jason Kelly",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6aa9cf5c-046c-4ffc-bac8-66fbcff75a8b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.52
      },
      "kind": "quote",
      "text": "Same lab technology as Zymergen, both were using the same supplier; CEO’s “biggest fear was always Zymergen”",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bdfbc53-96c6-4837-b807-8e5ede937a5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "quote",
      "text": "Ginkgo was worried and tried to downplay its similarity to Zymergen after its stock collapsed",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f8435e0-e629-4820-a60d-3e0aafced2f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.86
      },
      "kind": "quote",
      "text": "“They’re very similar”; some minor differences in vertical targeted",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "951e9e71-f5c2-4ac8-9b6a-e37d24d98061",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.58
      },
      "kind": "quote",
      "text": "“Zymergen was doing the same thing, and Sartorius is a major company that's one of the huge suppliers in the industry. When I was at Ginkgo, Jason's biggest fear was always Zymergen. And so, he would try to corner the market by buying all the equipment so Zymergen couldn't buy any. Just stuff like that. There are very few suppliers for this type of equipment.” - Former Ginkgo executive",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de2afa10-c1cd-4fc3-9cf7-6c353afc57a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"When I was at Ginkgo, Jason's biggest fear was always Zymergen. And so, he would try to corner the market by buying all the equipment so Zymergen couldn't buy any.\" — Former Ginkgo executive; \"Ginkgo was quickly in defensive mode [after Zymergen's stock collapsed] because they didn't want people to make that comparison, and so they announced all these deals to try to be able to show that they're different. Maybe Ginkgo will be successful at some point, but when the rubber meets the road, you look at what products are out there. Who has been successful using your technology that has led to a meaningful product? And the answer is there isn't any.\" — Former Ginkgo executive; \"I think that in certain ways, they're very similar. They competed on a number of very large-dollar number projects...I would say where Ginkgo and Zymergen diverged was a few years ago, Zymergen started to specialize in a few application areas: materials, ag, pharma, a few other one-offs. Whereas Ginkgo said, we're not going to specialize. We want to be able to engineer everything. And so, the types of projects that the company took on varied from cannabis projects to materials to biodefense.\" — Former Ginkgo employee, longtime direct report to CEO Jason Kelly",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-2b63-72e1-b602-4252323c41fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.05,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98265448-3617-40c1-a492-a9a484ecb293",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "One ex-employee of Ginkgo after another stated that Zymergen and Ginkgo are virtually identical animals.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7700bea8-679f-4a1c-9de9-cdca06817b8b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "expose_contradiction",
      "slug": null,
      "matchId": "3a3e8e88-5ba6-4336-9ead-ffd30d8b5836",
      "evidence": "Uses testimonials to highlight the gap between company narrative and internal reality.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 175,
      "from": 9,
      "beatId": "ffe290af-3a4f-4e06-8d60-dfbfc07d2e08",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The deck presents evidence contradicting Ginkgo's claims and highlighting potential wrongdoings.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}